Peptide Synthesis Market to Witness 13.0% CAGR by 2031 | SkyQuest Technology
Westford, USA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Peptide Synthesis Market Size will attain the value of USD 1861.20 Million by 2031, with a CAGR of 13.0% during the forecast period (2024-2031). Imaging technology demand is growing substantially for accurate diagnosis of chronic diseases. The use of biosensors and biomarkers for invasive and non-invasive diagnostics is also very common. Peptide based biosensors and biomarkers are experiencing huge demand growth fueling the peptide synthesis industry. Health care costs are rising sharply in developed countries of North America and Europe. Personalized medicine is growing due to rising healthcare costs, affordable alternative therapies. Personalized medicine and peptide-based medical solutions are expected to grow over the forecast period to drive market demand.
Browse in-depth TOC on "Peptide Synthesis Market "
- Pages – 162
- Tables - 119
- Figures – 70
To Learn More About This Report, Request a Free Sample Copy - https://www.skyquestt.com/sample-request/peptide-synthesis-market
Peptide Synthesis Market Overview:
| Report Coverage | Details |
| Market Revenue in 2023 | USD 700.11 Million |
| Estimated Value by 2031 | USD 1861.20 Million |
| Growth Rate | Poised to grow at a CAGR of 13.0% |
| Forecast Period | 2024–2031 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product & Service, Technology, End-user and Region |
| Geographies Covered | North America, Europe, Asia Pacific, Middle East & Africa, Latin America |
| Report Highlights | Heavy Funding from Government and Private Entities |
| Key Market Opportunities | Rise in the Peptide Based Therapeutics Demand |
| Key Market Drivers | Growing Demand for Imaging Based Diagnosis |
Personalized Therapeutics Segment to Dominate Due to Rising Demand for Personalized Medicine
As per peptide synthesis market outlook, the personalized therapeutics segment dominates with the largest revenue share. The demand for generic medicines is much higher due to better treatment of both chronic and chronic diseases. The prevalence of peptide-based diagnostics and therapies has dramatically increased the demand for personalized medicine during the pandemic.
Make an Inquiry to Address your Specific Business Needs: https://www.skyquestt.com/speak-with-analyst/peptide-synthesis-market
Contract Research Organizations Segment is Growing Due to Increased Funding for Research Organizations
The demand for peptide synthesis is expected to grow at the fastest pace for the contract research organizations segment during the forecast period. There has been a significant increase in the number of contract research organizations in developed countries and Asia-Pacific countries. Availability of skilled resources and funding is growing for contract research organizations. Additionally, the market has witnessed collaboration among major pharmaceutical companies, government agencies and contract research organizations, increasing the demand for this end-user segment.
North America is Dominating Due to Growing Healthcare Supply Chain
As per peptide synthesis market analysis, North America dominates due to high healthcare spending and growing healthcare supply chain. North America is home to some of the largest pharmaceutical companies in the world. These players are investing significantly in R&D with the cumulative R&D cost of the pharmaceutical companies in the US accounting to more than USD 95 billion in 2023. The increasing incidence of chronic diseases in North America is also increasing the demand for peptide manufacturing in this region.
Peptide Synthesis Market Insight
Drivers
- Growing Demand for Imaging Based Diagnosis
- Increasing Acceptance of Personalized Medicine and Therapeutics
- Rising Investments along with Huge Funding for R&D of Genomics and Proteomics in Bio-pharmaceutical Industry
Restraints
- Lack of Standardization
- Strict Regulatory Framework
- Issues Pertaining to Large-scale Peptide Synthesis and Lack of Robust Distribution Network
Take Action Now: Secure Your Peptide Synthesis Market Today - https://www.skyquestt.com/buy-now/peptide-synthesis-market
Prominent Players in Peptide Synthesis Market
- MERCK KGAA
- THERMO FISHER SCIENTIFIC
- GENSCRIPT BIOTECH CORPORATION
- BACHEM HOLDING AG
- KANEKA CORPORATION
- BIOTAGE AB
- SYNGENE INTERNATIONAL LIMITED
- MESA LABORATORIES, INC.
- CEM CORPORATION
- PROTEOGENIX
- BIO-SYNTHESIS INC.
- DALTON PHARMA SERVICES
- AAPPTEC
- VIVITIDE
- ANYGEN CO., LTD.
- ADVANCED CHEMTECH
- LUXEMBOURG BIO TECHNOLOGIES LTD.
- JPT PEPTIDE TECHNOLOGIES GMBH
- AMBIOPHARM INC.
- AURIGENE PHARMACEUTICAL SERVICES LTD
Key Questions Answered in Peptide Synthesis Market Report
- How big is the market?
- Which is the fastest growing region in the market?
- Which region has the biggest share in the market?
- What is the current size of the market?
Read Peptide Synthesis Market Report Today - https://www.skyquestt.com/report/peptide-synthesis-market
This report provides the following insights:
Analysis of key drivers (rising investments along with huge funding for R&D of genomics and proteomics in bio-pharmaceutical industry), restraints (lack of standardization, strict regulatory framework), opportunities (rise in the peptide-based therapeutics demand) influencing the growth of peptide synthesis market.
- Market Dynamics: Comprehensive information about the various products offered by the dominant players in the peptide synthesis market.
- Product Development/Innovation: An overview of emerging trends, R&D activities and product launches in the peptide synthesis market.
- Market Growth: Detailed information on profitable growing industries.
- Market Trends: Complete information about new products, emerging geographical areas and recent developments in the market.
- Competitive Analysis: An in-depth analysis of the market segments, growth strategies, revenue analysis, and products of the key market players.
Related Reports:
North America Mosquito Repellent Market is growing at a CAGR of 36.87% in the forecast period (2024-2031)
Pharmaceutical Analytical Testing Outsourcing Market is growing at a CAGR of 8.42% in the forecast period (2024-2031)
Parenteral Nutrition Market is growing at a CAGR of 7.6% in the forecast period (2024-2031)
Drug Delivery Market is growing at a CAGR of 8.4% in the forecast period (2024-2031)
U.S. Healthcare Staffing Market is growing at a CAGR of 5.66% in the forecast period (2024-2031)
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Us:
Mr. Jagraj Singh
Skyquest Technology
1 Apache Way,
Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: sales@skyquestt.com
Visit Our Website: https://www.skyquestt.com/
© Copyright Globe Newswire, Inc. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Globe Newswire, Inc.
